filmov
tv
Estudio EMPA-KIDNEY
Показать описание
Sociedad Española de Cardiología
cardiología
Рекомендации по теме
0:05:15
EMPA-KIDNEY
0:10:25
Estudio EMPA-KIDNEY
0:01:35
EMPA-KIDNEY: meta-analysis results
0:03:21
EMPA CKD - 3 min trial summary
0:01:52
EMPA-KIDNEY results: Empagliflozin reduces kidney disease progression and cardiovascular deaths
0:48:26
Empa-kidney: Empagliflozin in patients with chronic kidney disease - Dr. Julian Ocampo
0:01:14
EMPA-KIDNEY results November 2022
0:57:22
Emerging data from EMPA-KIDNEY study
0:10:10
EMPA-Kidney Results
0:04:10
Estudio STOP-ACEi
0:38:48
Radcliffe & CardioNerds @AHA22: EMPA-Kidney: Empagliflozin & CV Outcomes in Patients with CK...
0:07:23
Empa Kidney Trial
0:05:38
ESC TV On the Road - #AHA22 - DCP and EMPA-KIDNEY trials
1:27:20
VÑ ECA EMPA KIDNEY 2y, ERC [Empagliflozina vs Placebo]
0:48:38
KDIGO Leitlinien DM & CKD / EMPA-Kidney - Prof. Wanner
0:31:40
DR KAPIL SEJPAL EMPA kidney trial
1:08:25
Webinar: Overview of high impact clinical trials: EMPA-Kidney and STOP-ACEi
0:14:36
EMPA-REG OUTCOME
1:44:12
Uso clínico de inhibidores de SGLT2 en ERC: Documento de Consenso de SLANH 2024
0:09:06
SGLT2 Inhibitors in Chronic Kidney Disease
0:36:19
O ARTIGO MAIS IMPORTANTE DA NEFROLOGIA EM 2022 (EMPA-KIDNEY)
0:06:50
ACCess Points: Innovative Late-Breaking AHA 2022 Science Addressing Renal Disease; ACS | AHA 2022
0:43:57
Resultados del subestudio renal del EMPA-REG
0:10:52
O que o estudo EMPA-KIDNEY traz para a prática do dia a dia?
0:05:15
0:10:25
0:01:35
0:03:21
0:01:52
0:48:26
0:01:14
0:57:22
0:10:10
0:04:10
0:38:48
0:07:23
0:05:38
1:27:20
0:48:38
0:31:40
1:08:25
0:14:36
1:44:12
0:09:06
0:36:19
0:06:50
0:43:57
0:10:52